Fresenius Medical Care is one of the larger players in the dialysis market. As the dialysis market in the United States continues to grow Fresenius Medical Care is in a position to take full advantage of this industry. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives. At its current price point, Fresenius Medical Care is attractive for investors looking to get into the healthcare industry. As for the lease term they offer a 15 year NNN lease with various rental escalations built into the base term of the lease.